BioCentury Director of Biopharma Intelligence Karen Tkach Tuzman previewed a forthcoming analysis of preclinical papers published in the Distillery, BioCentury’s coverage of translational science, and Washington Editor Steve Usdin describes the latest on anti-China bills in Congress and Inflation Reduction Act litigation. Plus Stephen Hansen discusses Closed Loop Medicine Ltd.’s program that seeks to bring precision medicine to obesity — without limiting market size.

Listen in here from 19 min 30 sec.